Evidence map›Paper›PMID 31828726›Full record

ArticleJournal of gastrointestinal cancer2020

Author Correction: Prediction of Response to Neoadjuvant Chemoradiotherapy by MRI-Based Machine Learning Texture Analysis in Rectal Cancer Patients.

Sajad P Shayesteh, Afsaneh Alikhassi, Farshid Farhan, Reza Ghalehtaki, Masume Soltanabadi, Peiman Haddad, Ahmad Bitarafan-Rajabi

Abstract readPublished Erratum
In one paragraph

Article in Journal of gastrointestinal cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Sajad P ShayestehDepartment of Physiology, Pharmacology and Medical Physics, Faculty of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
Afsaneh AlikhassiDepartment of Radiology, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran.
Farshid FarhanRadiation Oncology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Reza GhalehtakiRadiation Oncology Department, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Masume SoltanabadiDepartment of Nuclear Medicine, Faculty of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Chaharmahal and Bakhtiari, Iran.
Peiman HaddadRadiation Oncology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran. haddad@tums.ac.ir.
Ahmad Bitarafan-RajabiCardiovascular Intervention Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran. bitarafan@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The original version of this article unfortunately contained a mistake. In the author group section, the correct name of the fourth author is "Reza Ghalehtaki." The authors apologize for this oversight and for any confusion it may have caused.

Identifiers

PMID31828726
PMCPMC7645568

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.